. Targeting Selective Activation of M(1) for the Treatment of Alzheimer's Disease: Further Chemical Optimization and Pharmacological Characterization of the M(1) Positive Allosteric Modulator ML169. ACS Chem Neurosci. 2012 Nov 21;3(11):884-95. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.